Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? ^67.9%

STAT - By Lizzy Lawrence - 6/23/2026, 8:30 AM

Biased Writer Voice 65.6% - Hasty Generalization 48.7% - Appeal to Authority 45.5%

WASHINGTON — Millions of Americans with obesity are eagerly awaiting a powerful new drug from Eli Lilly called retatrutide, which has demonstrated bariatric-surgery levels of weight loss. Some aren’t even waiting for approval from the Food and Drug Administration, instead racing to acquire it through sketchy means. But STAT has learned... more